ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® 2024 Insights: "Avelumab in Early TNBC With Residual Disease After Neoadjuvant Chemo or at High Risk After Primary Surgery and Adjuvant Chemo"
By
ecancer
FEATURING
Pierfranco Conte
By
ecancer
FEATURING
Pierfranco Conte
Comments 0
Login to view comments.
Click here to Login
